NASDAQ : PLRZ
Polyrizon Ltd. — Company profile
Healthcare · Biotechnology · Israel
Last price 10.75 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 26.11M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.
Details
| Name | Polyrizon Ltd. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 4 |
| Founded | 2005 |
| Ipo Date | 2024-10-29 |
| Ceo | Tomer Izraeli |
| Country | Israel |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 4.38 |
| Isin | IL0011814113 |
| Cusip | M79549206 |
| Cik | 1893645 |
| Sic | 3841 |
Key executives
| Name | Title |
|---|---|
| Tomer Izraeli | Founder, Chief Executive Officer and Director |
| Nir Ben Yosef | Chief Financial Officer and Compliance Officer |
| Dr. Tidhar Turgeman | Chief Technology Officer |
| Dr. Eyal S. Ron Ph.D. | Chief Scientific Officer |
Contact
| Address | 5 HaPnina Street, Ra'anana, 4321545, Israel |
| Phone | 972 9 374 0120 |
| Website | https://www.polyrizon-biotech.com |